日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The real-world effectiveness and safety of off-label rituximab in a large cohort of Middle Eastern multiple sclerosis patients

在中东多发性硬化症患者中，利妥昔单抗超适应症用药的真实世界疗效和安全性研究

期刊:Neurotherapeutics
影响因子:6.9
doi:10.1016/j.neurot.2026.e00861
Ismail, Ghida; Zeineddine, Maya; Al-Roughani, Raed; Ahmed, Samar Farouk; Al-Mahdawi, Akram; Khoury, Samia; El-Ayoubi, Nabil; Inshasi, Jihad; Al-Khabouri, Jaber; Al-Asmi, Abdullah; Gouider, Riadh; Aljarallah, Salman; Alkhawajah, Nuha; Al Malik, Yaser; Abulaban, Ahmad; Makkawi, Seraj; Khojah, Osama; El-Hajj, Taghrid; Massouh, Joelle; AlSalamat, Husam; Al-Hajje, Amal; Salameh, Pascale; Boumediene, Farid; Yamout, Bassem
神经科学
多发性硬化症
发表日期：2026
文献求助 收藏

Disease-Modifying Therapies, Outcomes, Risk Factors and Severity of COVID-19 in Multiple Sclerosis: A MENACTRIMS Registry Based Study

多发性硬化症患者的疾病修饰疗法、预后、风险因素及 COVID-19 严重程度：一项基于 MENACTRIMS 注册研究

期刊:Environmental Pollution
影响因子:7.3
doi:10.1016/j.envpol.2020.115859
Travaglio, Marco; Yu, Yizhou; Popovic, Rebeka; Selley, Liza; Leal, Nuno Santos; Martins, Luis Miguel; Zeineddine, Maya; Boumediene, Farid; Al-Hajje, Amal; Salameh, Pascale; Massouh, Joelle; Saab, Georges; Al-Roughani, Raed; Al-Mahdawi, Akram; Shalaby, Nevin; Inshasi, Jihad; Sahraian, Mohamad Ali; Gouider, Riadh; Mrabet, Saloua; Al-Khabouri, Jaber; Shaygannejad, Vahid; Chentouf, Amina; Yamout, Bassem
神经科学
多发性硬化症
发表日期：2023
文献求助 收藏

Adherence to subcutaneous interferon beta-1a treatment among patients with relapsing multiple sclerosis: the MAIN-MS study

复发型多发性硬化症患者对皮下注射干扰素β-1a治疗的依从性：MAIN-MS研究

期刊:Frontiers in Neurology
影响因子:2.8
doi:10.3389/fneur.2023.1257455
Al-Roughani, Raed; Zakaria, Magd; Cupler, Edward J; Taha, Karim
神经科学
多发性硬化症
发表日期：2023
文献求助 收藏